HELIX SYNDROME
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hypermagnesemia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Hypocalciuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypohidrosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypokalemia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Polyuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Xerostomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Polydipsia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dry skin
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Intolerant of heat
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alacrima
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypermagnesemia result
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Renal Insufficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dry Skin, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypermagnesemia, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Disseminated Intravascular Coagulation
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations:</b> DAMA, discharged against medical advice; DIC, disseminated intravascular coagulation; HELIX, Hypothermia for Encephalopathy in Low- and Middle-Income Countries Trial; HIE, hypoxic ischaemic encephalopathy; IP, ice packs; LMIC, low- and middle-income countries; NICHD, National Institute of Child Health and Human Development; PCM, phase changing; TH, therapeutic hypothermia (TH); TOBY, total body hypothermia for neonatal encephalopathy.
|
30109814 |
2019 |
Encephalopathies
|
0.020 |
GeneticVariation
|
group |
BEFREE |
<b>Abbreviations:</b> DAMA, discharged against medical advice; DIC, disseminated intravascular coagulation; HELIX, Hypothermia for Encephalopathy in Low- and Middle-Income Countries Trial; HIE, hypoxic ischaemic encephalopathy; IP, ice packs; LMIC, low- and middle-income countries; NICHD, National Institute of Child Health and Human Development; PCM, phase changing; TH, therapeutic hypothermia (TH); TOBY, total body hypothermia for neonatal encephalopathy.
|
30109814 |
2019 |
Hypoxic-Ischemic Encephalopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations:</b> DAMA, discharged against medical advice; DIC, disseminated intravascular coagulation; HELIX, Hypothermia for Encephalopathy in Low- and Middle-Income Countries Trial; HIE, hypoxic ischaemic encephalopathy; IP, ice packs; LMIC, low- and middle-income countries; NICHD, National Institute of Child Health and Human Development; PCM, phase changing; TH, therapeutic hypothermia (TH); TOBY, total body hypothermia for neonatal encephalopathy.
|
30109814 |
2019 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
<i>In vitro</i>, CLDN10 could promote cellular proliferation, migration, and invasion in PTC cell lines.
|
30588256 |
2018 |
Metabolic Syndrome X
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: <i>PTEN</i>-opathies and precision medicine.
|
29792313 |
2018 |
Pheochromocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma.
|
29794110 |
2018 |
Adrenal Gland Pheochromocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma.
|
29794110 |
2018 |
Hereditary Malignant Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
65 YEARS OF THE DOUBLE HELIX: The advancements of gene editing and potential application to hereditary cancer.
|
29980644 |
2018 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics.
|
29980645 |
2018 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
|
8167548 |
1994 |